Luciferase-expressing Leishmania infantum allows the monitoring of amastigote population size, in vivo, ex vivo and in vitro.
Here we engineered transgenic Leishmania infantum that express luciferase, the objectives being to more easily monitor in real time their establishment either in BALB/c mice--the liver and spleen being mainly studied-or in vitro. Whatever stationary phase L. infantum promastigotes population--wild t...
Main Authors: | Grégory Michel, Bernard Ferrua, Thierry Lang, Madhavi P Maddugoda, Patrick Munro, Christelle Pomares, Emmanuel Lemichez, Pierre Marty |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-09-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC3172198?pdf=render |
Similar Items
-
New diarylsulfonamide inhibitors of Leishmania infantum amastigotes
by: Myriam González, et al.
Published: (2021-08-01) -
In vivo involvement of polymorphonuclear neutrophils in Leishmania infantum infection
by: Le Fichoux Yves, et al.
Published: (2001-08-01) -
Immunoadjuvant Properties of the Rho Activating Factor CNF1 in Prophylactic and Curative Vaccination against Leishmania infantum.
by: Grégory Michel, et al.
Published: (2016-01-01) -
Detection of amastigotes and histopathological alterations in the thymus of Leishmania infantum‐infected dogs
by: Aurea V. A. daSilva, et al.
Published: (2020-06-01) -
Comparison of cell-mediated immunity due to Leishmania infantum promastigotes and axenic amastigotes
by: A Najafi-Dastanaei, et al.
Published: (2018-12-01)